Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Impact of CT attenuation correction by SPECT/CT in brain perfusion images.
Ishii K, Hanaoka K, Okada M, Kumano S, Komeya Y, Tsuchiya N, Hosono M, Murakami T.
Ann Nucl Med. 2012 Apr;26(3):241-7. doi: 10.1007/s12149-011-0567-y. Epub 2012 Jan 26.
Related citations
Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination.
Shirone N, Shinkai T, Yamane T, Uto F, Yoshimura H, Tamai H, Imai T, Inoue M, Kitano S, Kichikawa K, Hasegawa M.
Ann Nucl Med. 2012 Apr;26(3):248-52. doi: 10.1007/s12149-011-0568-x. Epub 2012 Jan 21.
Comparison of animal studies between interstitial magnetic resonance lymphography and radiocolloid SPECT/CT lymphoscintigraphy in the head and neck region.
Kitamura N, Kosuda S, Araki K, Tomifuji M, Mizokami D, Shiotani A, Shinmoto H, Fujii H, Ichihara K.
Ann Nucl Med. 2012 Apr;26(3):281-5. doi: 10.1007/s12149-011-0565-0. Epub 2012 Jan 12.
Interobserver variability, and visual and quantitative parameters of (123)I-FP-CIT SPECT (DaTSCAN) studies.
Papathanasiou N, Rondogianni P, Chroni P, Themistocleous M, Boviatsis E, Pedeli X, Sakas D, Datseris I.
Ann Nucl Med. 2012 Apr;26(3):234-40. doi: 10.1007/s12149-011-0564-1. Epub 2012 Jan 12.
PET scanning in plastic and reconstructive surgery.
Eirini L, Emmanouil L, Othonas P, Hans-Günther M, Nikolaos PA.
Ann Nucl Med. 2012 Feb;26(2):115-22. Epub 2012 Jan 6.
Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT.
Watabe T, Tatsumi M, Watabe H, Isohashi K, Kato H, Yanagawa M, Shimosegawa E, Hatazawa J.
Ann Nucl Med. 2012 Apr;26(3):222-7. doi: 10.1007/s12149-011-0562-3. Epub 2011 Dec 21.
Monte Carlo simulation of scintillation photons for the design of a high-resolution SPECT detector dedicated to human brain.
Hirano Y, Zeniya T, Iida H.
Ann Nucl Med. 2012 Apr;26(3):214-21. doi: 10.1007/s12149-011-0561-4. Epub 2011 Dec 13.
FDG-PET performed concurrently with initial I-131 ablation for differentiated thyroid cancer.
Iwano S, Kato K, Ito S, Tsuchiya K, Naganawa S.
Ann Nucl Med. 2012 Apr;26(3):207-13. doi: 10.1007/s12149-011-0559-y. Epub 2011 Dec 10.
The agreement of left ventricular function parameters between (99m)Tc-tetrofosmin gated myocardial SPECT and gated myocardial MRI.
Kuroiwa Y, Nagamachi S, Miyati T, Yamaguchi K, Nishii R, Kuga N, Azuma T, Arita H, Maeda M, Tamura S, Kawai K.
Ann Nucl Med. 2012 Feb;26(2):147-63. Epub 2011 Nov 12.
Advances in PET myocardial perfusion imaging: F-18 labeled tracers.
Rischpler C, Park MJ, Fung GS, Javadi M, Tsui BM, Higuchi T.
Ann Nucl Med. 2012 Jan;26(1):1-6. doi: 10.1007/s12149-011-0552-5. Epub 2011 Nov 9.
Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
Shiiba M, Ishihara K, Kimura G, Kuwako T, Yoshihara N, Sato H, Kondo Y, Tsuchiya S, Kumita S.
Ann Nucl Med. 2012 Feb;26(2):138-45. Epub 2011 Nov 9.
Impact of FDG-PET/CT in the management of lymphoma.
Baba S, Abe K, Isoda T, Maruoka Y, Sasaki M, Honda H.
Ann Nucl Med. 2011 Dec;25(10):701-16. Epub 2011 Oct 29. Review.
Fast Monte Carlo-simulator with full collimator and detector response modelling for SPECT.
Sohlberg AO, Kajaste MT.
Ann Nucl Med. 2012 Jan;26(1):92-8. doi: 10.1007/s12149-011-0550-7. Epub 2011 Oct 28.
The interpolated projection data estimation method improves the image quality of myocardial perfusion SPECT with a short acquisition time.
Asao K, Takaki A, Tominaga M, Sasaki M.
Ann Nucl Med. 2012 Feb;26(2):123-30. Epub 2011 Oct 28.
Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT.
Song YS, Oh SW, Kim YK, Kim SK, Wang KC, Lee DS.
Ann Nucl Med. 2012 Jan;26(1):47-57. doi: 10.1007/s12149-011-0541-8. Epub 2011 Oct 28.
Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
Bannas P, Derlin T, Groth M, Apostolova I, Adam G, Mester J, Klutmann S.
Ann Nucl Med. 2012 Jan;26(1):77-85. doi: 10.1007/s12149-011-0545-4. Epub 2011 Oct 19.
Cancer screening by FDG-PET: benefit or risk?
Hatazawa J.
Ann Nucl Med. 2011 Nov;25(9):667-8. No abstract available.
High resolution SPECT imaging for visualization of intratumoral heterogeneity using a SPECT/CT scanner dedicated for small animal imaging.
Umeda IO, Tani K, Tsuda K, Kobayashi M, Ogata M, Kimura S, Yoshimoto M, Kojima S, Moribe K, Yamamoto K, Moriyama N, Fujii H.
Ann Nucl Med. 2012 Jan;26(1):67-76. doi: 10.1007/s12149-011-0542-7. Epub 2011 Oct 12.
Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Na SJ, Yoo IeR, O JH, Lin C, Lin Q, Kim SH, Chung SK.
Ann Nucl Med. 2012 Jan;26(1):26-34. doi: 10.1007/s12149-011-0536-5. Epub 2011 Oct 5.
FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
Koolen BB, Vegt E, Rutgers EJ, Vogel WV, Stokkel MP, Hoefnagel CA, Fioole-Bruining A, Vrancken Peeters MJ, Valdés Olmos RA.
Ann Nucl Med. 2012 Jan;26(1):86-91. doi: 10.1007/s12149-011-0538-3. Epub 2011 Sep 28.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on